Author

Habib Hamidi

GenentechORCID 0000-0003-0196-9852Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Habib Hamidi1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adam B. OlsheniD· 1 shared Alexander E. PerliD· 1 shared Andrew Koh· 1 shared Anushka WaliaiD· 1 shared Attaya SuvannasankhaiD· 1 shared Bogdan Ovidiu PopescuiD· 1 shared Brenda ChylaiD· 1 shared Brian A. WalkeriD· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam B. OlshenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsGenome MedicinePeer-reviewedJul 15, 2025

Utilizing Genomics to Identify Novel Immunotherapeutic Targets in Multiple Myeloma High-Risk Subgroups

Enze Liu, Oumaima Jaouadi, Riya Sharma…·Brian A. Walker

The paper identifies novel immunotherapeutic targets in multiple myeloma high-risk subgroups using genomic data integration and validation.

3 citations

humanwhole-exome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 2, 2025

RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance

Vanessa Elaine Kennedy, Cheryl A.C. Peretz, Anushka Walia…·Catherine Choy Smith

4 citations

𝕏 PostBluesky

Cancer BiologyMolecular OncologyPeer-reviewedJan 23, 2025

Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial Dysfunction

Connor S. Murphy, Heather E. Fairfield, Victoria E. DeMambro…·Michaela Ruth Reagan

This study shows that inhibiting ACSLs in multiple myeloma cells reduces proliferation and causes mitochondrial dysfunction, suggesting ACSLs as potential therapeutic targets.

18 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky